Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

71%

5 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
3(42.9%)
Phase 2
2(28.6%)
Phase 4
2(28.6%)
7Total
Phase 3(3)
Phase 2(2)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT01777503Phase 4Completed

The Elderly ACS II Trial

Role: collaborator

NCT01969890Phase 3Terminated

STem cElls Mobilization in Acute Myocardial Infarction Outcome Trial

Role: collaborator

NCT00687258Phase 2Completed

Evaluation Of A New Vitamin E-Bonded Membrane On Anemia And Oxidative Stress In End-Stage Renal Disease Patients

Role: lead

NCT01009957Phase 2Terminated

Everolimus on CKD Progression in ADPKD Patients

Role: lead

NCT01583309Phase 3Completed

Effects of Convective Therapies in Dialysis Patients

Role: lead

NCT01392833Phase 3Completed

Steroids and Azathioprine in Advanced IgAN

Role: lead

NCT00755859Phase 4Completed

"Steroids and Azathioprine Versus Steroids Alone in IgAN"

Role: lead

All 7 trials loaded